Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/82656
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Fibrosis and cirrhosis reversibility - molecular mechanisms
Author: Gieling, R.
Burt, A.
Mann, D.
Citation: Clinics in Liver Disease, 2008; 12(4):915-937
Publisher: WB Saunders Co
Issue Date: 2008
ISSN: 1089-3261
1557-8224
Statement of
Responsibility: 
Roben G. Gieling, Alastair D. Burt, Derek A. Mann
Abstract: The concept that liver fibrosis is a dynamic process with potential for regression as well as progression has emerged in parallel with clinical evidence for remodeling of fibrotic extracellular matrix in patients who can be effectively treated for their underlying cause of liver disease. This article reviews recent discoveries relating to the cellular and molecular mechanisms that regulate fibrosis regression, with emphasis on studies that have used experimental in vivo models of liver disease. Apoptosis of hepatic myofibroblasts is discussed. The functions played by transcription factors, receptor-ligand interactions, and cell-matrix interactions as regulators of the lifespan of hepatic myofibroblasts are considered, as are the therapeutic opportunities for modulating these functions. Growth factors, proteolytic enzymes, and their inhibitors are discussed in detail
Keywords: Hepatic myofibroblasts
Apoptosis
NF-κB
Fibrosis
Extracellular matrix
Neovascularisation
Rights: © 2008 Elsevier Inc. All rights reserved.
DOI: 10.1016/j.cld.2008.07.001
Published version: http://dx.doi.org/10.1016/j.cld.2008.07.001
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.